Global NGS-Based Monitoring and Diagnostic Test Market Research Report 2024(Status and Outlook)
Report Overview
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
This report provides a deep insight into the global NGS-Based Monitoring and Diagnostic Test market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NGS-Based Monitoring and Diagnostic Test Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NGS-Based Monitoring and Diagnostic Test market in any manner.
Global NGS-Based Monitoring and Diagnostic Test Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Market Segmentation (by Type)
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Market Segmentation (by Application)
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-Based Monitoring and Diagnostic Test Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
NGS-Based Monitoring and Diagnostic Test is based on the NGS, aiming for the monitoring and diagnostic test. Next generation sequencing (NGS), massively parallel or deep sequencing are related terms that describe a DNA sequencing technology which has revolutionised genomic research. Using NGS an entire human genome can be sequenced within a single day.
This report provides a deep insight into the global NGS-Based Monitoring and Diagnostic Test market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global NGS-Based Monitoring and Diagnostic Test Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the NGS-Based Monitoring and Diagnostic Test market in any manner.
Global NGS-Based Monitoring and Diagnostic Test Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technologies, Inc.
Ancestry.com LLC
ArcherDX, Inc.
Beijing Genomics Institute (BGI)
Cancer Genetics, Inc.
CENTOGENE AG
F. Hoffmann-La Roche Ltd
GenePath Dx
Illumina, Inc.
Laboratory Corporation of America Holdings
Myriad Genetics, Inc.
QIAGEN N.V.
Quest Diagnostics Incorporated
Siemens Healthineers, Inc.
Thermo Fisher Scientific Inc.
HTG Molecular Diagnostics, Inc.
Vela Diagnostics Pte. Ltd.
Market Segmentation (by Type)
Commercial Assays/Tests
Laboratory Developed Tests
Direct to Consumer Test
Pre-Commercial Tests
Market Segmentation (by Application)
Out-Patient Clinics/General Practitioners
Diagnostic Centers
Hospitals
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the NGS-Based Monitoring and Diagnostic Test Market
- Overview of the regional outlook of the NGS-Based Monitoring and Diagnostic Test Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the NGS-Based Monitoring and Diagnostic Test Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of NGS-Based Monitoring and Diagnostic Test
1.2 Key Market Segments
1.2.1 NGS-Based Monitoring and Diagnostic Test Segment by Type
1.2.2 NGS-Based Monitoring and Diagnostic Test Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NGS-Based Monitoring and Diagnostic Test Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET COMPETITIVE LANDSCAPE
3.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Manufacturers (2019-2024)
3.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Manufacturers (2019-2024)
3.3 NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NGS-Based Monitoring and Diagnostic Test Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NGS-Based Monitoring and Diagnostic Test Sales Sites, Area Served, Product Type
3.6 NGS-Based Monitoring and Diagnostic Test Market Competitive Situation and Trends
3.6.1 NGS-Based Monitoring and Diagnostic Test Market Concentration Rate
3.6.2 Global 5 and 10 Largest NGS-Based Monitoring and Diagnostic Test Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NGS-BASED MONITORING AND DIAGNOSTIC TEST INDUSTRY CHAIN ANALYSIS
4.1 NGS-Based Monitoring and Diagnostic Test Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2019-2024)
6.3 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2019-2024)
6.4 Global NGS-Based Monitoring and Diagnostic Test Price by Type (2019-2024)
7 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-Based Monitoring and Diagnostic Test Market Sales by Application (2019-2024)
7.3 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) by Application (2019-2024)
7.4 Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
8 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY REGION
8.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Region
8.1.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Region
8.1.2 Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region
8.2 North America
8.2.1 North America NGS-Based Monitoring and Diagnostic Test Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NGS-Based Monitoring and Diagnostic Test Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NGS-Based Monitoring and Diagnostic Test Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies, Inc.
9.1.1 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.1.2 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.1.4 Agilent Technologies, Inc. Business Overview
9.1.5 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.1.6 Agilent Technologies, Inc. Recent Developments
9.2 Ancestry.com LLC
9.2.1 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Basic Information
9.2.2 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Overview
9.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.2.4 Ancestry.com LLC Business Overview
9.2.5 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.2.6 Ancestry.com LLC Recent Developments
9.3 ArcherDX, Inc.
9.3.1 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.3.2 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.3.5 ArcherDX, Inc. Business Overview
9.3.6 ArcherDX, Inc. Recent Developments
9.4 Beijing Genomics Institute (BGI)
9.4.1 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Basic Information
9.4.2 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Overview
9.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.4.4 Beijing Genomics Institute (BGI) Business Overview
9.4.5 Beijing Genomics Institute (BGI) Recent Developments
9.5 Cancer Genetics, Inc.
9.5.1 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.5.2 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.5.4 Cancer Genetics, Inc. Business Overview
9.5.5 Cancer Genetics, Inc. Recent Developments
9.6 CENTOGENE AG
9.6.1 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Basic Information
9.6.2 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Overview
9.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.6.4 CENTOGENE AG Business Overview
9.6.5 CENTOGENE AG Recent Developments
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Basic Information
9.7.2 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Overview
9.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.7.4 F. Hoffmann-La Roche Ltd Business Overview
9.7.5 F. Hoffmann-La Roche Ltd Recent Developments
9.8 GenePath Dx
9.8.1 GenePath Dx NGS-Based Monitoring and Diagnostic Test Basic Information
9.8.2 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Overview
9.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.8.4 GenePath Dx Business Overview
9.8.5 GenePath Dx Recent Developments
9.9 Illumina, Inc.
9.9.1 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.9.2 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.9.4 Illumina, Inc. Business Overview
9.9.5 Illumina, Inc. Recent Developments
9.10 Laboratory Corporation of America Holdings
9.10.1 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Basic Information
9.10.2 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Overview
9.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.10.4 Laboratory Corporation of America Holdings Business Overview
9.10.5 Laboratory Corporation of America Holdings Recent Developments
9.11 Myriad Genetics, Inc.
9.11.1 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.11.2 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.11.4 Myriad Genetics, Inc. Business Overview
9.11.5 Myriad Genetics, Inc. Recent Developments
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Basic Information
9.12.2 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Overview
9.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.12.4 QIAGEN N.V. Business Overview
9.12.5 QIAGEN N.V. Recent Developments
9.13 Quest Diagnostics Incorporated
9.13.1 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Basic Information
9.13.2 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Overview
9.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.13.4 Quest Diagnostics Incorporated Business Overview
9.13.5 Quest Diagnostics Incorporated Recent Developments
9.14 Siemens Healthineers, Inc.
9.14.1 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.14.2 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.14.4 Siemens Healthineers, Inc. Business Overview
9.14.5 Siemens Healthineers, Inc. Recent Developments
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.15.2 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.15.4 Thermo Fisher Scientific Inc. Business Overview
9.15.5 Thermo Fisher Scientific Inc. Recent Developments
9.16 HTG Molecular Diagnostics, Inc.
9.16.1 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.16.2 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.16.4 HTG Molecular Diagnostics, Inc. Business Overview
9.16.5 HTG Molecular Diagnostics, Inc. Recent Developments
9.17 Vela Diagnostics Pte. Ltd.
9.17.1 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Basic Information
9.17.2 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Overview
9.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.17.4 Vela Diagnostics Pte. Ltd. Business Overview
9.17.5 Vela Diagnostics Pte. Ltd. Recent Developments
10 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET FORECAST BY REGION
10.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast
10.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country
10.2.3 Asia Pacific NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region
10.2.4 South America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NGS-Based Monitoring and Diagnostic Test by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NGS-Based Monitoring and Diagnostic Test by Type (2025-2030)
11.1.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NGS-Based Monitoring and Diagnostic Test by Type (2025-2030)
11.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Application (2025-2030)
11.2.1 Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) Forecast by Application
11.2.2 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of NGS-Based Monitoring and Diagnostic Test
1.2 Key Market Segments
1.2.1 NGS-Based Monitoring and Diagnostic Test Segment by Type
1.2.2 NGS-Based Monitoring and Diagnostic Test Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global NGS-Based Monitoring and Diagnostic Test Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET COMPETITIVE LANDSCAPE
3.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Manufacturers (2019-2024)
3.2 Global NGS-Based Monitoring and Diagnostic Test Revenue Market Share by Manufacturers (2019-2024)
3.3 NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global NGS-Based Monitoring and Diagnostic Test Average Price by Manufacturers (2019-2024)
3.5 Manufacturers NGS-Based Monitoring and Diagnostic Test Sales Sites, Area Served, Product Type
3.6 NGS-Based Monitoring and Diagnostic Test Market Competitive Situation and Trends
3.6.1 NGS-Based Monitoring and Diagnostic Test Market Concentration Rate
3.6.2 Global 5 and 10 Largest NGS-Based Monitoring and Diagnostic Test Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NGS-BASED MONITORING AND DIAGNOSTIC TEST INDUSTRY CHAIN ANALYSIS
4.1 NGS-Based Monitoring and Diagnostic Test Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2019-2024)
6.3 Global NGS-Based Monitoring and Diagnostic Test Market Size Market Share by Type (2019-2024)
6.4 Global NGS-Based Monitoring and Diagnostic Test Price by Type (2019-2024)
7 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global NGS-Based Monitoring and Diagnostic Test Market Sales by Application (2019-2024)
7.3 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) by Application (2019-2024)
7.4 Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
8 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET SEGMENTATION BY REGION
8.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Region
8.1.1 Global NGS-Based Monitoring and Diagnostic Test Sales by Region
8.1.2 Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region
8.2 North America
8.2.1 North America NGS-Based Monitoring and Diagnostic Test Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe NGS-Based Monitoring and Diagnostic Test Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America NGS-Based Monitoring and Diagnostic Test Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technologies, Inc.
9.1.1 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.1.2 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.1.3 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.1.4 Agilent Technologies, Inc. Business Overview
9.1.5 Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.1.6 Agilent Technologies, Inc. Recent Developments
9.2 Ancestry.com LLC
9.2.1 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Basic Information
9.2.2 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Overview
9.2.3 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.2.4 Ancestry.com LLC Business Overview
9.2.5 Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.2.6 Ancestry.com LLC Recent Developments
9.3 ArcherDX, Inc.
9.3.1 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.3.2 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.3.3 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.3.4 ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
9.3.5 ArcherDX, Inc. Business Overview
9.3.6 ArcherDX, Inc. Recent Developments
9.4 Beijing Genomics Institute (BGI)
9.4.1 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Basic Information
9.4.2 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Overview
9.4.3 Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.4.4 Beijing Genomics Institute (BGI) Business Overview
9.4.5 Beijing Genomics Institute (BGI) Recent Developments
9.5 Cancer Genetics, Inc.
9.5.1 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.5.2 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.5.3 Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.5.4 Cancer Genetics, Inc. Business Overview
9.5.5 Cancer Genetics, Inc. Recent Developments
9.6 CENTOGENE AG
9.6.1 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Basic Information
9.6.2 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Overview
9.6.3 CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.6.4 CENTOGENE AG Business Overview
9.6.5 CENTOGENE AG Recent Developments
9.7 F. Hoffmann-La Roche Ltd
9.7.1 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Basic Information
9.7.2 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Overview
9.7.3 F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.7.4 F. Hoffmann-La Roche Ltd Business Overview
9.7.5 F. Hoffmann-La Roche Ltd Recent Developments
9.8 GenePath Dx
9.8.1 GenePath Dx NGS-Based Monitoring and Diagnostic Test Basic Information
9.8.2 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Overview
9.8.3 GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.8.4 GenePath Dx Business Overview
9.8.5 GenePath Dx Recent Developments
9.9 Illumina, Inc.
9.9.1 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.9.2 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.9.3 Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.9.4 Illumina, Inc. Business Overview
9.9.5 Illumina, Inc. Recent Developments
9.10 Laboratory Corporation of America Holdings
9.10.1 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Basic Information
9.10.2 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Overview
9.10.3 Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.10.4 Laboratory Corporation of America Holdings Business Overview
9.10.5 Laboratory Corporation of America Holdings Recent Developments
9.11 Myriad Genetics, Inc.
9.11.1 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.11.2 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.11.3 Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.11.4 Myriad Genetics, Inc. Business Overview
9.11.5 Myriad Genetics, Inc. Recent Developments
9.12 QIAGEN N.V.
9.12.1 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Basic Information
9.12.2 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Overview
9.12.3 QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.12.4 QIAGEN N.V. Business Overview
9.12.5 QIAGEN N.V. Recent Developments
9.13 Quest Diagnostics Incorporated
9.13.1 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Basic Information
9.13.2 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Overview
9.13.3 Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.13.4 Quest Diagnostics Incorporated Business Overview
9.13.5 Quest Diagnostics Incorporated Recent Developments
9.14 Siemens Healthineers, Inc.
9.14.1 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.14.2 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.14.3 Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.14.4 Siemens Healthineers, Inc. Business Overview
9.14.5 Siemens Healthineers, Inc. Recent Developments
9.15 Thermo Fisher Scientific Inc.
9.15.1 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.15.2 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.15.3 Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.15.4 Thermo Fisher Scientific Inc. Business Overview
9.15.5 Thermo Fisher Scientific Inc. Recent Developments
9.16 HTG Molecular Diagnostics, Inc.
9.16.1 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
9.16.2 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
9.16.3 HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.16.4 HTG Molecular Diagnostics, Inc. Business Overview
9.16.5 HTG Molecular Diagnostics, Inc. Recent Developments
9.17 Vela Diagnostics Pte. Ltd.
9.17.1 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Basic Information
9.17.2 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Overview
9.17.3 Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Market Performance
9.17.4 Vela Diagnostics Pte. Ltd. Business Overview
9.17.5 Vela Diagnostics Pte. Ltd. Recent Developments
10 NGS-BASED MONITORING AND DIAGNOSTIC TEST MARKET FORECAST BY REGION
10.1 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast
10.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country
10.2.3 Asia Pacific NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region
10.2.4 South America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of NGS-Based Monitoring and Diagnostic Test by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of NGS-Based Monitoring and Diagnostic Test by Type (2025-2030)
11.1.2 Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of NGS-Based Monitoring and Diagnostic Test by Type (2025-2030)
11.2 Global NGS-Based Monitoring and Diagnostic Test Market Forecast by Application (2025-2030)
11.2.1 Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) Forecast by Application
11.2.2 Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Region (M USD)
Table 5. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NGS-Based Monitoring and Diagnostic Test Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2022)
Table 10. Global Market NGS-Based Monitoring and Diagnostic Test Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NGS-Based Monitoring and Diagnostic Test Sales Sites and Area Served
Table 12. Manufacturers NGS-Based Monitoring and Diagnostic Test Product Type
Table 13. Global NGS-Based Monitoring and Diagnostic Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NGS-Based Monitoring and Diagnostic Test
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-Based Monitoring and Diagnostic Test Market Challenges
Table 22. Global NGS-Based Monitoring and Diagnostic Test Sales by Type (K Units)
Table 23. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (M USD)
Table 24. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Type (2019-2024)
Table 25. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2019-2024)
Table 26. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) by Type (2019-2024)
Table 27. Global NGS-Based Monitoring and Diagnostic Test Market Size Share by Type (2019-2024)
Table 28. Global NGS-Based Monitoring and Diagnostic Test Price (USD/Unit) by Type (2019-2024)
Table 29. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Application
Table 30. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application
Table 31. Global NGS-Based Monitoring and Diagnostic Test Sales by Application (2019-2024) & (K Units)
Table 32. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2019-2024)
Table 33. Global NGS-Based Monitoring and Diagnostic Test Sales by Application (2019-2024) & (M USD)
Table 34. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2019-2024)
Table 35. Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
Table 36. Global NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 37. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region (2019-2024)
Table 38. North America NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 39. Europe NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 41. South America NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 44. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 45. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies, Inc. Business Overview
Table 47. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 48. Agilent Technologies, Inc. Recent Developments
Table 49. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Basic Information
Table 50. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Overview
Table 51. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Ancestry.com LLC Business Overview
Table 53. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 54. Ancestry.com LLC Recent Developments
Table 55. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 56. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 57. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 59. ArcherDX, Inc. Business Overview
Table 60. ArcherDX, Inc. Recent Developments
Table 61. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Basic Information
Table 62. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Overview
Table 63. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Beijing Genomics Institute (BGI) Business Overview
Table 65. Beijing Genomics Institute (BGI) Recent Developments
Table 66. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 67. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 68. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cancer Genetics, Inc. Business Overview
Table 70. Cancer Genetics, Inc. Recent Developments
Table 71. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Basic Information
Table 72. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Overview
Table 73. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. CENTOGENE AG Business Overview
Table 75. CENTOGENE AG Recent Developments
Table 76. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Basic Information
Table 77. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Overview
Table 78. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd Recent Developments
Table 81. GenePath Dx NGS-Based Monitoring and Diagnostic Test Basic Information
Table 82. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Overview
Table 83. GenePath Dx NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GenePath Dx Business Overview
Table 85. GenePath Dx Recent Developments
Table 86. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 87. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 88. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Illumina, Inc. Business Overview
Table 90. Illumina, Inc. Recent Developments
Table 91. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Basic Information
Table 92. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Overview
Table 93. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings Recent Developments
Table 96. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 97. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 98. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics, Inc. Business Overview
Table 100. Myriad Genetics, Inc. Recent Developments
Table 101. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 102. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 103. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. QIAGEN N.V. Business Overview
Table 105. QIAGEN N.V. Recent Developments
Table 106. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Basic Information
Table 107. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Overview
Table 108. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Quest Diagnostics Incorporated Business Overview
Table 110. Quest Diagnostics Incorporated Recent Developments
Table 111. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 112. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 113. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Siemens Healthineers, Inc. Business Overview
Table 115. Siemens Healthineers, Inc. Recent Developments
Table 116. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 117. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 118. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Thermo Fisher Scientific Inc. Business Overview
Table 120. Thermo Fisher Scientific Inc. Recent Developments
Table 121. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 122. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 123. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. HTG Molecular Diagnostics, Inc. Business Overview
Table 125. HTG Molecular Diagnostics, Inc. Recent Developments
Table 126. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 127. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 128. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vela Diagnostics Pte. Ltd. Business Overview
Table 130. Vela Diagnostics Pte. Ltd. Recent Developments
Table 131. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global NGS-Based Monitoring and Diagnostic Test Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. NGS-Based Monitoring and Diagnostic Test Market Size Comparison by Region (M USD)
Table 5. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Manufacturers (2019-2024)
Table 7. Global NGS-Based Monitoring and Diagnostic Test Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-Based Monitoring and Diagnostic Test as of 2022)
Table 10. Global Market NGS-Based Monitoring and Diagnostic Test Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers NGS-Based Monitoring and Diagnostic Test Sales Sites and Area Served
Table 12. Manufacturers NGS-Based Monitoring and Diagnostic Test Product Type
Table 13. Global NGS-Based Monitoring and Diagnostic Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of NGS-Based Monitoring and Diagnostic Test
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. NGS-Based Monitoring and Diagnostic Test Market Challenges
Table 22. Global NGS-Based Monitoring and Diagnostic Test Sales by Type (K Units)
Table 23. Global NGS-Based Monitoring and Diagnostic Test Market Size by Type (M USD)
Table 24. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Type (2019-2024)
Table 25. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Type (2019-2024)
Table 26. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) by Type (2019-2024)
Table 27. Global NGS-Based Monitoring and Diagnostic Test Market Size Share by Type (2019-2024)
Table 28. Global NGS-Based Monitoring and Diagnostic Test Price (USD/Unit) by Type (2019-2024)
Table 29. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) by Application
Table 30. Global NGS-Based Monitoring and Diagnostic Test Market Size by Application
Table 31. Global NGS-Based Monitoring and Diagnostic Test Sales by Application (2019-2024) & (K Units)
Table 32. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2019-2024)
Table 33. Global NGS-Based Monitoring and Diagnostic Test Sales by Application (2019-2024) & (M USD)
Table 34. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2019-2024)
Table 35. Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
Table 36. Global NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 37. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region (2019-2024)
Table 38. North America NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 39. Europe NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 41. South America NGS-Based Monitoring and Diagnostic Test Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 44. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 45. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technologies, Inc. Business Overview
Table 47. Agilent Technologies, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 48. Agilent Technologies, Inc. Recent Developments
Table 49. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Basic Information
Table 50. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Product Overview
Table 51. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Ancestry.com LLC Business Overview
Table 53. Ancestry.com LLC NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 54. Ancestry.com LLC Recent Developments
Table 55. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 56. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 57. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ArcherDX, Inc. NGS-Based Monitoring and Diagnostic Test SWOT Analysis
Table 59. ArcherDX, Inc. Business Overview
Table 60. ArcherDX, Inc. Recent Developments
Table 61. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Basic Information
Table 62. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Product Overview
Table 63. Beijing Genomics Institute (BGI) NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Beijing Genomics Institute (BGI) Business Overview
Table 65. Beijing Genomics Institute (BGI) Recent Developments
Table 66. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 67. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 68. Cancer Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cancer Genetics, Inc. Business Overview
Table 70. Cancer Genetics, Inc. Recent Developments
Table 71. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Basic Information
Table 72. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Product Overview
Table 73. CENTOGENE AG NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. CENTOGENE AG Business Overview
Table 75. CENTOGENE AG Recent Developments
Table 76. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Basic Information
Table 77. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Product Overview
Table 78. F. Hoffmann-La Roche Ltd NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. F. Hoffmann-La Roche Ltd Business Overview
Table 80. F. Hoffmann-La Roche Ltd Recent Developments
Table 81. GenePath Dx NGS-Based Monitoring and Diagnostic Test Basic Information
Table 82. GenePath Dx NGS-Based Monitoring and Diagnostic Test Product Overview
Table 83. GenePath Dx NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. GenePath Dx Business Overview
Table 85. GenePath Dx Recent Developments
Table 86. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 87. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 88. Illumina, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Illumina, Inc. Business Overview
Table 90. Illumina, Inc. Recent Developments
Table 91. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Basic Information
Table 92. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Product Overview
Table 93. Laboratory Corporation of America Holdings NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Laboratory Corporation of America Holdings Business Overview
Table 95. Laboratory Corporation of America Holdings Recent Developments
Table 96. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 97. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 98. Myriad Genetics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Myriad Genetics, Inc. Business Overview
Table 100. Myriad Genetics, Inc. Recent Developments
Table 101. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 102. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 103. QIAGEN N.V. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. QIAGEN N.V. Business Overview
Table 105. QIAGEN N.V. Recent Developments
Table 106. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Basic Information
Table 107. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Product Overview
Table 108. Quest Diagnostics Incorporated NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Quest Diagnostics Incorporated Business Overview
Table 110. Quest Diagnostics Incorporated Recent Developments
Table 111. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 112. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 113. Siemens Healthineers, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Siemens Healthineers, Inc. Business Overview
Table 115. Siemens Healthineers, Inc. Recent Developments
Table 116. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 117. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 118. Thermo Fisher Scientific Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Thermo Fisher Scientific Inc. Business Overview
Table 120. Thermo Fisher Scientific Inc. Recent Developments
Table 121. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 122. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 123. HTG Molecular Diagnostics, Inc. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. HTG Molecular Diagnostics, Inc. Business Overview
Table 125. HTG Molecular Diagnostics, Inc. Recent Developments
Table 126. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Basic Information
Table 127. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Product Overview
Table 128. Vela Diagnostics Pte. Ltd. NGS-Based Monitoring and Diagnostic Test Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vela Diagnostics Pte. Ltd. Business Overview
Table 130. Vela Diagnostics Pte. Ltd. Recent Developments
Table 131. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Region (2025-2030) & (K Units)
Table 132. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region (2025-2030) & (M USD)
Table 133. North America NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 134. North America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 135. Europe NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 136. Europe NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 137. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Forecast by Region (2025-2030) & (K Units)
Table 138. Asia Pacific NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Region (2025-2030) & (M USD)
Table 139. South America NGS-Based Monitoring and Diagnostic Test Sales Forecast by Country (2025-2030) & (K Units)
Table 140. South America NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 141. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Consumption Forecast by Country (2025-2030) & (Units)
Table 142. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Country (2025-2030) & (M USD)
Table 143. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Type (2025-2030) & (K Units)
Table 144. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Type (2025-2030) & (M USD)
Table 145. Global NGS-Based Monitoring and Diagnostic Test Price Forecast by Type (2025-2030) & (USD/Unit)
Table 146. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) Forecast by Application (2025-2030)
Table 147. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of NGS-Based Monitoring and Diagnostic Test
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD), 2019-2030
Figure 5. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) (2019-2030)
Figure 6. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-Based Monitoring and Diagnostic Test Market Size by Country (M USD)
Figure 11. NGS-Based Monitoring and Diagnostic Test Sales Share by Manufacturers in 2023
Figure 12. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Manufacturers in 2023
Figure 13. NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NGS-Based Monitoring and Diagnostic Test Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type
Figure 18. Sales Market Share of NGS-Based Monitoring and Diagnostic Test by Type (2019-2024)
Figure 19. Sales Market Share of NGS-Based Monitoring and Diagnostic Test by Type in 2023
Figure 20. Market Size Share of NGS-Based Monitoring and Diagnostic Test by Type (2019-2024)
Figure 21. Market Size Market Share of NGS-Based Monitoring and Diagnostic Test by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application
Figure 24. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2019-2024)
Figure 25. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application in 2023
Figure 26. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2019-2024)
Figure 27. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application in 2023
Figure 28. Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
Figure 29. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region (2019-2024)
Figure 30. North America NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 32. U.S. NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NGS-Based Monitoring and Diagnostic Test Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NGS-Based Monitoring and Diagnostic Test Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 37. Germany NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region in 2023
Figure 44. China NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 50. South America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 51. Brazil NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Type (2025-2030)
Figure 65. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Application (2025-2030)
Figure 66. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of NGS-Based Monitoring and Diagnostic Test
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD), 2019-2030
Figure 5. Global NGS-Based Monitoring and Diagnostic Test Market Size (M USD) (2019-2030)
Figure 6. Global NGS-Based Monitoring and Diagnostic Test Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. NGS-Based Monitoring and Diagnostic Test Market Size by Country (M USD)
Figure 11. NGS-Based Monitoring and Diagnostic Test Sales Share by Manufacturers in 2023
Figure 12. Global NGS-Based Monitoring and Diagnostic Test Revenue Share by Manufacturers in 2023
Figure 13. NGS-Based Monitoring and Diagnostic Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market NGS-Based Monitoring and Diagnostic Test Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by NGS-Based Monitoring and Diagnostic Test Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global NGS-Based Monitoring and Diagnostic Test Market Share by Type
Figure 18. Sales Market Share of NGS-Based Monitoring and Diagnostic Test by Type (2019-2024)
Figure 19. Sales Market Share of NGS-Based Monitoring and Diagnostic Test by Type in 2023
Figure 20. Market Size Share of NGS-Based Monitoring and Diagnostic Test by Type (2019-2024)
Figure 21. Market Size Market Share of NGS-Based Monitoring and Diagnostic Test by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application
Figure 24. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application (2019-2024)
Figure 25. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Application in 2023
Figure 26. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application (2019-2024)
Figure 27. Global NGS-Based Monitoring and Diagnostic Test Market Share by Application in 2023
Figure 28. Global NGS-Based Monitoring and Diagnostic Test Sales Growth Rate by Application (2019-2024)
Figure 29. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region (2019-2024)
Figure 30. North America NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 32. U.S. NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada NGS-Based Monitoring and Diagnostic Test Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico NGS-Based Monitoring and Diagnostic Test Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 37. Germany NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 43. Asia Pacific NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region in 2023
Figure 44. China NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 50. South America NGS-Based Monitoring and Diagnostic Test Sales Market Share by Country in 2023
Figure 51. Brazil NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa NGS-Based Monitoring and Diagnostic Test Sales Market Share by Region in 2023
Figure 56. Saudi Arabia NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa NGS-Based Monitoring and Diagnostic Test Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global NGS-Based Monitoring and Diagnostic Test Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global NGS-Based Monitoring and Diagnostic Test Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Type (2025-2030)
Figure 65. Global NGS-Based Monitoring and Diagnostic Test Sales Forecast by Application (2025-2030)
Figure 66. Global NGS-Based Monitoring and Diagnostic Test Market Share Forecast by Application (2025-2030)
